[1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate

C43H70N4O5 — CID 144550928

IUPAC[1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate
SMILESCC(C)C(OC(=O)N1CCC1)C1CCC2C(CC3C4CCC5C(C)(C)[C@@H](OC(=O)NCCN6CCN(C7CCC7)CC6)CCC56C[C@@]46CCC23C)O1
InChIInChI=1S/C43H70N4O5/c1-28(2)37(52-39(49)47-19-7-20-47)33-12-10-31-34(50-33)26-32-30-11-13-35-40(3,4)36(14-15-43(35)27-42(30,43)17-16-41(31,32)5)51-38(48)44-18-21-45-22-24-46(25-23-45)29-8-6-9-29/h28-37H,6-27H2,1-5H3,(H,44,48)/t30?,31?,32?,33?,34?,35?,36-,37?,41?,42-,43?/m0/s1
InChIKeyCBVGKRRAHOQOLO-UYHTUYNDSA-N
MW723.06 g/mol
LogP7.32
Rot. Bonds8

About [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate

[1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate (PubChem CID 144550928) has the molecular formula C43H70N4O5 and a molecular weight of 723.06 g/mol. Its IUPAC name is [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate.

Molecular Properties

Compound Name[1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate
PubChem CID144550928
Molecular FormulaC43H70N4O5
Molecular Weight723.06 g/mol
Exact Mass722.53
IUPAC Name[1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate
SMILESCC(C)C(OC(=O)N1CCC1)C1CCC2C(CC3C4CCC5C(C)(C)[C@@H](OC(=O)NCCN6CCN(C7CCC7)CC6)CCC56C[C@@]46CCC23C)O1
InChIInChI=1S/C43H70N4O5/c1-28(2)37(52-39(49)47-19-7-20-47)33-12-10-31-34(50-33)26-32-30-11-13-35-40(3,4)36(14-15-43(35)27-42(30,43)17-16-41(31,32)5)51-38(48)44-18-21-45-22-24-46(25-23-45)29-8-6-9-29/h28-37H,6-27H2,1-5H3,(H,44,48)/t30?,31?,32?,33?,34?,35?,36-,37?,41?,42-,43?/m0/s1
InChIKeyCBVGKRRAHOQOLO-UYHTUYNDSA-N
XLogP7.32
TPSA83.58 Ų
H-Bond Donors1
H-Bond Acceptors7
Rotatable Bonds8
Heavy Atoms52
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500723.06
LogP ≤ 57.32
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 107

Analyze [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate?
The IUPAC name of [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate (CID 144550928) is [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate.
What is the SMILES notation for [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate?
The canonical SMILES for [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate is CC(C)C(OC(=O)N1CCC1)C1CCC2C(CC3C4CCC5C(C)(C)[C@@H](OC(=O)NCCN6CCN(C7CCC7)CC6)CCC56C[C@@]46CCC23C)O1.
What is the InChIKey of [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate?
The InChIKey is CBVGKRRAHOQOLO-UYHTUYNDSA-N. The full InChI is InChI=1S/C43H70N4O5/c1-28(2)37(52-39(49)47-19-7-20-47)33-12-10-31-34(50-33)26-32-30-11-13-35-40(3,4)36(14-15-43(35)27-42(30,43)17-16-41(31,32)5)51-38(48)44-18-21-45-22-24-46(25-23-45)29-8-6-9-29/h28-37H,6-27H2,1-5H3,(H,44,48)/t30?,31?,32?,33?,34?,35?,36-,37?,41?,42-,43?/m0/s1.
What are the key properties of [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate?
[1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate has a molecular weight of 723.06 g/mol, XLogP of 7.32, 8 rotatable bonds, 1 hydrogen bond donors, and 7 hydrogen bond acceptors.
Where does this data come from?
All data for [1-[(1S,18S)-18-[2-(4-cyclobutylpiperazin-1-yl)ethylcarbamoyloxy]-4,17,17-trimethyl-9-oxahexacyclo[11.9.0.01,21.04,12.05,10.016,21]docosan-8-yl]-2-methylpropyl] azetidine-1-carboxylate is sourced from PubChem (CID 144550928), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).